Immediate Impact
24 standout
Citing Papers
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Will Donnellan being referenced
PS945 KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: END OF PHASE 1 RESULTS OF ZUMA-3
2019
FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Will Donnellan | 37 | 45 | 15 | 18 | 5 | 71 | |
| R. Andrew Harkins | 25 | 40 | 7 | 7 | 7 | 64 | |
| T.B. Johannesen | 40 | 44 | 29 | 49 | 4 | 106 | |
| Ekaterina Chigrinova | 16 | 27 | 10 | 16 | 5 | 60 | |
| Elen Oliveira | 34 | 14 | 41 | 33 | 5 | 96 | |
| H Schouten | 51 | 37 | 5 | 19 | 6 | 76 | |
| Sandra Le Guyader-Peyrou | 38 | 54 | 16 | 8 | 5 | 74 | |
| Kerstin Busch | 40 | 95 | 27 | 16 | 5 | 164 | |
| Sunkyu Kim | 33 | 16 | 37 | 19 | 7 | 88 | |
| José Fernandes | 45 | 19 | 14 | 30 | 5 | 85 | |
| R. Scott Mead | 47 | 14 | 8 | 12 | 5 | 87 |
All Works
Loading papers...